George Wang, Ph.D.

Vice President of Discovery and Preclinical Development at WuXi Biologics

Speaker

Dr. George Wang, Vice President of Discovery and Preclinical Development Service at WuXi Biologics, currently is responsible for contract service of therapeutic proteins from concept to IND filing. Dr. Wang played various leadership roles since he joined WuXi Biologics, including managing antigen and antibody generation for over 300 discovery projects, establishing single domain antibody group, and developing several bispecific antibody platforms. He innovated the proprietary WuXiBodyTM bispecific antibody platform which has been licensed to 12+ clients with over $500 million deal value.

Prior to joining WuXi Biologics, Dr. Wang worked at Bayer Healthcare, contributed to several global projects from target to clinical development. He also participated evaluation and license-in of new technologies. Dr. Wang has authored over 20 publications in peer-reviewed journals and is the lead inventor on over 40 patents and patent applications. Dr. Wang obtained a Ph.D. in oncology from Peking University and an MBA from the University of California at Berkeley. He completed his post-doctoral training at Harvard Medical School.